{"address1": "100 Marine Parkway", "address2": "Suite 400", "city": "Redwood City", "state": "CA", "zip": "94065", "country": "United States", "phone": "650 213 8444", "fax": "650 213 8383", "website": "https://soleno.life", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.", "fullTimeEmployees": 92, "companyOfficers": [{"maxAge": 1, "name": "Dr. Anish  Bhatnagar M.D.", "age": 54, "title": "President, CEO, COO & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 1056800, "exercisedValue": 0, "unexercisedValue": 8917844}, {"maxAge": 1, "name": "Mr. James H. MacKaness", "age": 60, "title": "CFO & Compliance Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 640000, "exercisedValue": 0, "unexercisedValue": 1407576}, {"maxAge": 1, "name": "Ms. Patricia C. Hirano M.P.H.", "age": 58, "title": "Senior Vice President of Regulatory Affairs", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 493000, "exercisedValue": 0, "unexercisedValue": 1616281}, {"maxAge": 1, "name": "Mr. Jesse  Schumaker", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lauren  Budesheim", "title": "Vice President of People", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristen  Yen M.S.", "age": 55, "title": "Senior Vice President of Clinical Operations", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 317190, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil M. Cowen M.B.A., Ph.D.", "title": "Senior Vice President of Drug Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Meredith  Manning M.B.A.", "age": 51, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Huang M.D.", "age": 50, "title": "Senior Vice President of Clinical Development", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mitchell  Nagao M.B.A., Pharm.D.", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 8, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 71.45, "open": 70.11, "dayLow": 66.5, "dayHigh": 71.29, "regularMarketPreviousClose": 71.45, "regularMarketOpen": 70.11, "regularMarketDayLow": 66.5, "regularMarketDayHigh": 71.29, "payoutRatio": 0.0, "beta": -1.694, "forwardPE": -30.070486, "volume": 1901654, "regularMarketVolume": 1901654, "averageVolume": 942858, "averageVolume10days": 3182510, "averageDailyVolume10Day": 3182510, "bid": 66.97, "ask": 69.57, "bidSize": 9, "askSize": 9, "marketCap": 3130219520, "fiftyTwoWeekLow": 36.61, "fiftyTwoWeekHigh": 73.968, "fiftyDayAverage": 49.817, "twoHundredDayAverage": 49.12315, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2891607808, "profitMargins": 0.0, "floatShares": 31072442, "sharesOutstanding": 45857300, "sharesShort": 4987722, "sharesShortPriorMonth": 4540445, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.1088, "heldPercentInsiders": 0.02617, "heldPercentInstitutions": 1.09727, "shortRatio": 8.63, "shortPercentOfFloat": 0.1611, "impliedSharesOutstanding": 45857300, "bookValue": 5.363, "priceToBook": 12.727951, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -175850000, "trailingEps": -4.38, "forwardEps": -2.27, "lastSplitFactor": "1:15", "lastSplitDate": 1661472000, "enterpriseToEbitda": -15.849, "52WeekChange": 0.6345786, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 68.26, "targetHighPrice": 123.0, "targetLowPrice": 81.0, "targetMeanPrice": 102.125, "targetMedianPrice": 103.5, "recommendationMean": 1.375, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 291436992, "totalCashPerShare": 6.355, "ebitda": -182442000, "totalDebt": 52826000, "quickRatio": 15.546, "currentRatio": 15.677, "debtToEquity": 21.552, "returnOnAssets": -0.45056, "returnOnEquity": -0.87353, "freeCashflow": -7471500, "operatingCashflow": -69096000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLNO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1415889000000, "preMarketChange": -0.75, "preMarketChangePercent": -1.0987401, "preMarketPrice": 67.51, "marketState": "PRE", "regularMarketChangePercent": -4.4646535, "regularMarketPrice": 68.26, "shortName": "Soleno Therapeutics, Inc.", "longName": "Soleno Therapeutics, Inc.", "regularMarketChange": -3.1899948, "regularMarketDayRange": "66.5 - 71.29", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 942858, "fiftyTwoWeekLowChange": 31.650002, "fiftyTwoWeekLowChangePercent": 0.8645179, "fiftyTwoWeekRange": "36.61 - 73.968", "fiftyTwoWeekHighChange": -5.708, "fiftyTwoWeekHighChangePercent": -0.0771685, "fiftyTwoWeekChangePercent": 63.45786, "dividendDate": 1507248000, "earningsTimestamp": 1740690000, "earningsTimestampStart": 1746648000, "earningsTimestampEnd": 1747080000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.38, "epsForward": -2.27, "fiftyDayAverageChange": 18.443, "fiftyDayAverageChangePercent": 0.370215, "twoHundredDayAverageChange": 19.136852, "twoHundredDayAverageChangePercent": 0.38956892, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "corporateActions": [], "preMarketTime": 1743597305, "regularMarketTime": 1743537601, "exchange": "NCM", "messageBoardId": "finmb_2520553", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Soleno Therapeutics", "trailingPegRatio": null}